Tuesday, November 9, 2010

23andMe Raises More Than $22 million in Series C Financing

"We believe this round of financing will help us achieve our goal of dramatically accelerating the pace of research and could ultimately make health care research and health care delivery more efficient," said Anne Wojcicki, chief executive officer of 23andMe.

23andMe is actively recruiting for several key positions within the company. Available positions are listed on the company's website at https://www.23andme.com/about/jobs

This press release does not constitute or form part of, and should not be construed as an offer or an invitation to sell or issue, or the solicitation of any offer to buy or subscribe for, any securities.

Monday, November 8, 2010

Scientist in Nutritional Systems Biology : Lausanne, Switzerland


Nestlé Research Center (NRC) located near Lausanne, Switzerland is one of the leading research laboratories in food and nutritional sciences. With 700 members of staff from 50 nations, NRC has a strong position in the international scientific community supported further by more than 200 external scientific partnerships and University collaborations and 270 scientific publications each year .

NRC has an excellent reputation in food and nutrition research that has benefited consumers for over a century. By bringing together its knowledge in Nutrition and Health, Food Science, Food/Consumer Interaction, Food Quality and Safety, Nestlé opens the way to develop Good Food and Good Life: to offer tasty foods that procure health as well as pleasure for our consumers.

In this global and multicultural environment, Nestlé, a food, nutrition, health and wellness company aims to work with the best scientists in the world.

Sunday, November 7, 2010

Bacteria's Immune System Secret Unlocked


The secret of bacteria's immune system has been unlocked by scientists.

The team led by Professor Sylvain Moineau of Universiti Laval's Department of Biochemistry, Microbiology, and Bioinformatics showed that this mechanism, called CRISPR/Cas, works by selecting foreign DNA segments and inserting them into very specific locations in a bacterium's genome.

These segments then serve as a kind of immune factor in fighting off future invasions by cleaving incoming DNA.